Study Summary
This protocol is to ensure consistent long-term follow-up for delayed safety events in participants who received A2 Bio gene therapy (GT) products.
Interested in this trial?
Submit an InquiryInterventions
No additional intervention administered in this long term follow-up studyOTHER
Safety follow-up for A2 Bio GT products administered in a previous interventional study
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Banner Health | Gilbert | Arizona | United States |
| Mayo Clinic | Rochester | Minnesota | United States |
| NYU Langone Medical Center | New York | New York | United States |